NKp46/NCR1 Antibody (MM0491-8F24) - Azide and BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-11820
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human, Mouse
Cited:
Human, Mouse
Applications
Validated:
CyTOF-ready, Flow Cytometry, Immunohistochemistry, Immunohistochemistry-Frozen, Immunohistochemistry-Paraffin, Western Blot
Cited:
Immunohistochemistry-Paraffin
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG2 Clone # MM0491-8F24
Format
Azide and BSA Free
Concentration
LYOPH mg/ml
Product Specifications
Immunogen
Human recombinant NKp46/NCR1
Reactivity Notes
Mouse reactivity reported in scientific literature (PMID: 29078276).
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2
Scientific Data Images for NKp46/NCR1 Antibody (MM0491-8F24) - Azide and BSA Free
Immunohistochemistry-Paraffin: NKp46/NCR1 Antibody (MM0491-8F24) - Azide and BSA Free [NBP2-11820]
Immunohistochemistry-Paraffin: NKp46/NCR1 Antibody (MM0491-8F24) [NBP2-11820] - Human lymph node metastatsis section stained for Nkp46, antibody dilution 1:70, incubated O/N at 4C. Antigen retrieval in citrate buffer. Image from verified customer review.Immunohistochemistry-Frozen: NKp46/NCR1 Antibody (MM0491-8F24) - Azide and BSA Free [NBP2-11820]
Immunohistochemistry-Frozen: NKp46/NCR1 Antibody (MM0491-8F24) [NBP2-11820] - Mouse anti human NKp46 in diseased human liver tissues (frozen section).Applications for NKp46/NCR1 Antibody (MM0491-8F24) - Azide and BSA Free
Application
Recommended Usage
Flow Cytometry
1:50-1:100
Immunohistochemistry
1:10-1:500
Immunohistochemistry-Frozen
1:20-1:100
Western Blot
1:500-1:1000
Application Notes
This antibody is Cytof ready.
Reviewed Applications
Read 1 review rated 4 using NBP2-11820 in the following applications:
Formulation, Preparation, and Storage
Purification
Protein G purified
Reconstitution
Reconstitute with sterilized PBS to a final concentration of 0.5 mg/ml.
Formulation
Lyophilized from a 0.2 um filtered solution in PBS. 0.025 mg size is provided in liquid form, PBS
Format
Azide and BSA Free
Preservative
No Preservative
Concentration
LYOPH mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Background: NKp46/NCR1
NKp46 plays a critical role in the NK-cell lysis of allogenic, autologous, and xenogeneic cells (3). Activation of NKp46 signaling is mediated via its association with immunoreceptor tyrosine-based activation motif (ITAM) bearing molecules CD3zeta and FcRgamma (3). Upon receptor-engagement NK-cell cytotoxic activity and cytokine release occurs (3). This NKp46 signaling can be blocked with anti-NKp46 monoclonal antibody mediated cross-linking which causes calcium release and interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) secretion (3). NKp46 recognizes multiple ligands presented on tumor cells or pathogens and infected cells including influenza virus hemagglutinin and the parainfluenza virus hemagglutinin neuraminidase (2). Additional ligands for the NKp46 receptor include heparan sulfate (HS) glycosaminoglycans (GAGs), hemagglutinin of human vaccina virus, and vimentin expressed on cells infected with Mycobacterium tuberculosis (3).
NKp46 and its NCR counterparts have shown to be successful targets for cancer immunotherapy. More specifically, human and mouse NKp46 has shown promise in virotherapy due to its ability to stimulate NK cell activation by binding to reovirus sigma1 protein in a sialic acid-dependent manner (3). Another approach for NKp46 in cancer immunotherapy is through the use of NCR based chimeric antigen receptors (CARs). In this therapy, NCR1 supplied human T cells with anti-tumor properties via cytokine secretion, upregulation of activation markers, improved expansion, and cytotoxicity in both mouse and in vitro models (3).
References
1. Barrow, A. D., Martin, C. J., & Colonna, M. (2019). The Natural Cytotoxicity Receptors in Health and Disease. Frontiers in immunology, 10, 909. https://doi.org/10.3389/fimmu.2019.00909
2. Mandelboim, O., & Porgador, A. (2001). NKp46. The international journal of biochemistry & cell biology, 33(12), 1147-1150. https://doi.org/10.1016/S1357-2725(01)00078-4
3. Barrow, A. D., Martin, C. J., & Colonna, M. (2019). The Natural Cytotoxicity Receptors in Health and Disease. Frontiers in immunology, 10, 909. https://doi.org/10.3389/fimmu.2019.00909
Additional NKp46/NCR1 Products
Product Documents for NKp46/NCR1 Antibody (MM0491-8F24) - Azide and BSA Free
Product Specific Notices for NKp46/NCR1 Antibody (MM0491-8F24) - Azide and BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...